CAS Number: 1415456-99-3
Molecular Weight: 4409
Chemical Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Application: Agoniste du récepteur de l'amyline ; recherche sur l'obésité/la perte de poids
IUPAC Name: 20-[[(1S)-4-[[(2S)-6-amino-1-[[(4R,7S,10S,13S,16S,19R)-4-[[(2S)-1-[[(2S,3R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(
EC Number: 974-120-5
Pureté: Titre ≥98.0%
Type de formulation: Polypeptide cyclique de 38 acides aminés
Statut réglementaire: Matériau de qualité pharmaceutique (fabrication de médicaments)

Autres informations

Description supplémentaire:

Cagrilintide (CAS 1415456-99-3) is a novel long-acting acylated amylin analog manufactured directly by Nanjing Cellnuo Biopharmaceutical Co., Ltd. at pharmaceutical grade with purity above 98.0%. It is a cyclic 38-amino-acid polypeptide with a disulfide bond that acts as a non-selective agonist of the amylin receptor (AMYR) and calcitonin receptor (CTR), shown to reduce food intake and body weight in obesity research, and is distributed to Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.